Bernard Bénichou

5.2k total citations · 1 hit paper
29 papers, 4.0k citations indexed

About

Bernard Bénichou is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Bernard Bénichou has authored 29 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Bernard Bénichou's work include Trace Elements in Health (6 papers), Lysosomal Storage Disorders Research (5 papers) and Heavy Metal Exposure and Toxicity (4 papers). Bernard Bénichou is often cited by papers focused on Trace Elements in Health (6 papers), Lysosomal Storage Disorders Research (5 papers) and Heavy Metal Exposure and Toxicity (4 papers). Bernard Bénichou collaborates with scholars based in France, United States and Spain. Bernard Bénichou's co-authors include Judith Melki, Philippe Burlet, Olivier Clermont, Philippe Millasseau, Massimo Zeviani, Lydie Bürglen, Denis Le Paslier, Jean Weissenbach, Arnold Münnich and Corinne Cruaud and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bernard Bénichou

25 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification and characterization of a spinal muscular atrophy-determining gene

1995 3.1k citations Lydie Bürglen, Olivier Clermont et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard Bénichou France	17	2.9k	2.8k	1.1k	328	263	29	4.0k
Beril Talim Türkiye	31	3.0k 1.0×	487 0.2×	444 0.4×	405 1.2×	416 1.6×	138	4.0k
Richard J.L.F. Lemmers Netherlands	30	3.5k 1.2×	895 0.3×	246 0.2×	526 1.6×	194 0.7×	65	3.9k
Haiyan Zhou United Kingdom	32	1.8k 0.6×	764 0.3×	285 0.3×	250 0.8×	96 0.4×	74	2.3k
Samiah Al-Zaidy United States	15	1.3k 0.5×	614 0.2×	328 0.3×	652 2.0×	158 0.6×	26	1.8k
France Leturcq France	35	3.4k 1.2×	639 0.2×	311 0.3×	657 2.0×	538 2.0×	130	4.0k
Gary R. Coulton United Kingdom	20	1.7k 0.6×	374 0.1×	500 0.5×	247 0.8×	293 1.1×	41	2.1k
En Kimura Japan	24	1.1k 0.4×	288 0.1×	208 0.2×	270 0.8×	204 0.8×	86	1.7k
Harold S. Bernstein United States	29	1.7k 0.6×	257 0.1×	641 0.6×	146 0.4×	343 1.3×	67	2.7k
Manuela Gavina Italy	17	1.0k 0.4×	528 0.2×	470 0.4×	133 0.4×	163 0.6×	20	2.1k
J. F. Pellissier France	30	1.0k 0.4×	371 0.1×	225 0.2×	137 0.4×	196 0.7×	91	2.2k

Countries citing papers authored by Bernard Bénichou

Since Specialization

Citations

This map shows the geographic impact of Bernard Bénichou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Bénichou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Bénichou more than expected).

Fields of papers citing papers by Bernard Bénichou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Bénichou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Bénichou. The network helps show where Bernard Bénichou may publish in the future.

Co-authorship network of co-authors of Bernard Bénichou

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Bénichou. A scholar is included among the top collaborators of Bernard Bénichou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Bénichou. Bernard Bénichou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bénichou, Bernard, et al.. (2025). Pilot Clinical Study Showing Abnormal Copper Metabolism in Healthy Wilson Disease Heterozygote Subjects. Clinical and Translational Science. 18(7).

Garcelon, Nicolas, Bernard Bénichou, Jeanne Amiel, et al.. (2025). Evaluation of a New Inclusive Next‐Generation Synthetic Face Tool for Dysmorphology. American Journal of Medical Genetics Part A. 200(3). 685–694. 1 indexed citations

Bénichou, Bernard, et al.. (2024). Characteristics of patients with Wilson disease in the United States: An insurance claims database study. World Journal of Hepatology. 16(5). 791–799.

Gonzalès, Emmanuel, Antoine Gardin, Charlotte Mussini, et al.. (2023). Outcomes of 38 patients with PFIC3: Impact of genotype and of response to ursodeoxycholic acid therapy. JHEP Reports. 5(10). 100844–100844. 8 indexed citations

Lantero, Aquilino, Itsaso Mauleón, Johannes Häberle, et al.. (2022). Gene Therapy in Combination with Nitrogen Scavenger Pretreatment Corrects Biochemical and Behavioral Abnormalities of Infant Citrullinemia Type 1 Mice. International Journal of Molecular Sciences. 23(23). 14940–14940. 1 indexed citations

Murillo, Oihana, María Collantes, Cristina Gázquez, et al.. (2022). High value of 64Cu as a tool to evaluate the restoration of physiological copper excretion after gene therapy in Wilson’s disease. Molecular Therapy — Methods & Clinical Development. 26. 98–106. 18 indexed citations

Bénichou, Bernard, et al.. (2022). Epidemiology, treatment and burden of Wilson disease in France: A 10-year analysis of the national health insurance database. Clinics and Research in Hepatology and Gastroenterology. 46(10). 101992–101992. 9 indexed citations

Weber, Nicholas D., Leticia Odriozola, Anne Douar, et al.. (2019). Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model. Nature Communications. 10(1). 5694–5694. 28 indexed citations

Ramaswami, Uma, Daniel G. Bichet, L. Clarke, et al.. (2019). Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial. Molecular Genetics and Metabolism. 127(1). 86–94. 24 indexed citations

10.

Murillo, Oihana, Daniel Moreno, Cristina Gázquez, et al.. (2019). Liver Expression of a MiniATP7B Gene Results in Long‐Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice. Hepatology. 70(1). 108–126. 39 indexed citations

11.

Bénichou, Bernard, Jean‐Louis Bernard, Xavier Hébuterne, et al.. (2016). Les anti TNF α : facteur de risque de complications graves après résection iléocolique pour maladie de Crohn. Journal de Chirurgie Viscérale. 153(4). A29–A29.

12.

Wijburg, Frits A., Bernard Bénichou, Daniel G. Bichet, et al.. (2015). Characterization of Early Disease Status in Treatment-Naive Male Paediatric Patients with Fabry Disease Enrolled in a Randomized Clinical Trial. PLoS ONE. 10(5). e0124987–e0124987. 39 indexed citations

13.

Lubanda, Jean-Claude, et al.. (2009). Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease. Genetics in Medicine. 11(4). 256–264. 42 indexed citations

14.

Bénichou, Bernard, Sunita Goyal, Crystal Sung, Andrea M. Norfleet, & Fanny O’Brien. (2008). A retrospective analysis of the potential impact of IgG antibodies to agalsidase β on efficacy during enzyme replacement therapy for Fabry disease. Molecular Genetics and Metabolism. 96(1). 4–12. 86 indexed citations

15.

Trochu, Jean‐Noël, Florence Kyndt, Jean‐Jacques Schott, et al.. (2000). Clinical characteristics of a familial inherited myxomatous valvular dystrophy mapped to Xq28. Journal of the American College of Cardiology. 35(7). 1890–1897. 33 indexed citations

16.

Kyndt, Florence, Jean‐Jacques Schott, Jean‐Noël Trochu, et al.. (1998). Mapping of X-Linked Myxomatous Valvular Dystrophy to Chromosome Xq28. The American Journal of Human Genetics. 62(3). 627–632. 66 indexed citations

17.

Bénichou, Bernard, et al.. (1996). Possible misdiagnosis of factor VIII gene inversion in a case of severe hemophilia A [letter]. Blood. 87(8). 3525–3526. 2 indexed citations

18.

Matte, Úrsula da Silveira, et al.. (1996). Study on Possible Increase in Twinning Rate at a Small Village in South Brazil. Acta geneticae medicae et gemellologiae twin research. 45(4). 431–437. 17 indexed citations

19.

Bürglen, Lydie, Olivier Clermont, Philippe Burlet, et al.. (1995). Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 80(1). 155–165. 3069 indexed citations breakdown →

20.

Fournier, B., Jean Marie Saudubray, Bernard Bénichou, et al.. (1994). Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy.. Journal of Clinical Investigation. 94(2). 526–531. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact